Month: December 2020

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) — Griffin Industrial Realty, Inc. (Nasdaq: GRIF) (“Griffin” or the “Company”) announced the following updates on leasing and the impact of the COVID-19 pandemic on rent collections:LeasingGriffin reported the following for its industrial/warehouse portfolio for the three months ended November 30, 2020 (the “2020 fourth quarter”):Griffin’s industrial/warehouse portfolio’s percentage leased was as follows:Approximately 411,000 square feet of the 498,000 square feet renewed or leased during this quarter related to two lease renewals of existing tenants in the Lehigh Valley of Pennsylvania. One of these leases was an early 5-year renewal of 131,000 square feet leased to the subsidiary of a Fortune 500 company, increasing the remaining lease term to nearly 7 years, and the other was a 5-year renewal...

HOUSTON, Dec. 15, 2020 (GLOBE NEWSWIRE) — Recruiter.com Group, Inc. (OTCQB: RCRT), an AI-enabled hiring platform with the world’s largest network of recruiters, is pleased to announce a significant upgrade to its software platform.“We are excited to help our customers recruit talent faster using video, artificial intelligence technology, and virtual teams of on-demand recruiters. Our re-engineered platform integrates these capabilities into our core software and significantly upgrades our design, infrastructure, and usability,” said Evan Sohn, CEO of Recruiter.com. “Recruiter.com moves into the new year with an incredible opportunity and technical capability to help in the re-opening of our economy by enabling businesses of all sizes to recruit talent faster.”New Recruiter Hiring PlatformAI/Video features....

ATHENS, Greece, Dec. 15, 2020 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX) (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced the commencement of a tender offer to purchase up to 6,000,000 shares, or about 6.7%, of its outstanding common stock using funds available from cash and cash equivalents on hand at a price of $2.00 per share. The tender offer will expire at the end of the day, 5:00 P.M., Eastern Time, on January 14, 2021, unless extended or withdrawn. The Board of Directors determined that it is in the Company’s best interest to repurchase shares at this time given Diana Shipping’s cash position and stock price. The tender offer is not conditioned upon any minimum number of shares being tendered; however, the tender offer is subject to a number of other terms...

Company announcement – No. 62 / 2020Dasiglucagon on top of standard of care (SOC) did not significantly reduce the rate of hypoglycemia compared to SOC alone when assessed by intermittent self-measured plasma glucose (primary endpoint)However, hypoglycemia was reduced by 40–50% with dasiglucagon as compared to SOC alone when assessed by blinded continuous glucose monitoring (exploratory analysis)Dasiglucagon treatment was assessed to be safe and well tolerated in the study and 31 out of 32 patients continued into the long-term extension studyZealand Pharma will engage with regulatory authorities to discuss the results while awaiting the outcome of the second phase 3-trial in younger children with CHICopenhagen, December 15, 2020 – Zealand Pharma A/S (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused...

VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to report, in a descriptive format, positive trending interim data for the Phase 2b part of the Company’s Phase 2b/3 clinical study of Ifenprodil for COVID-19.For the endpoint of ventilation by day 15, there was a trend towards fewer patients requiring mechanical ventilation in the high dose Ifenprodil treatment arm, as compared to patients who were in the untreated arm of the study. Mechanical ventilation is associated with poor prognosis in COVID-19 patients, including increased risk of mortality and procedural complications.(1) In addition, extended duration of mechanical ventilation places an enormous...

SAN JOSE, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA), today announced the Katana Edge AI™ platform, addressing a growing industry gap for solutions that enable battery powered devices for consumer and industrial IoT markets. The platform combines Synaptics’ proven low power SoC architecture with energy-efficient AI software, enabled by a partnership with Eta Compute. The Katana solution is optimized for a wide range of ultra-low power use cases in edge devices for office buildings, retail, factories, farms and smart homes. Typical applications include people or object recognition and counting, visual, voice or sound detection, asset or inventory tracking and environmental sensing.The Most Power Efficient Edge AI SiliconKatana features a multi-core processor architecture optimized for ultra-low-power...

NEXT GAMES CORPORATION COMPANY RELEASE, 15 DECEMBER 2020, 3:00 p.m. EETNext Games Corp.: Financial Reporting and Annual General Meeting in 2021

EL DORADO, Ark., Dec. 15, 2020 (GLOBE NEWSWIRE) — Murphy USA Inc. (NYSE: MUSA) announces the grand opening of its 1500th location in Mesquite, Texas. The 2800 square foot Murphy Express will be open 24 hours and provide customers competitive low-priced gasoline along with a wide variety of convenience items. The site marks Murphy USA’s 47th store opening in 2020, including new to industry and raze & rebuild locations.“The opening of our 1500th location represents another important milestone for the company as we work to deliver on our goal of growing our network up to 50 new stores each year beginning in 2021,” said President and CEO, Andrew Clyde. Stephen Oliver, Director of Real Estate added, “The success in securing and opening new stores is a multi-year commitment that cannot be accomplished without the support of the entire...

HAMILTON, Bermuda, Dec. 15, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline of assets designed to modulate immunological pathways across a spectrum of diseases, today announced the commencement of dosing in the Phase 2b clinical trial of vixarelimab in prurigo nodularis, a chronic inflammatory skin condition characterized by severely pruritic skin nodules. Vixarelimab is a fully-human monoclonal antibody that targets oncostatin M receptor beta (OSMRβ). The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to vixarelimab for the treatment of pruritus associated with prurigo nodularis in 2020.“We are pleased to announce the commencement of dosing in the Phase 2b trial of vixarelimab in patients with prurigo nodularis. The study...